Partner Headlines - SLXP

  1. Santarus Wins Drug Approval, Offers Bullish Guidance

    Investors Business Daily

  2. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With ...

    Benzinga

  3. US Stock Futures Higher On Fiscal-Cliff Deal

    Benzinga

  4. FDA Approves Fulyzaq 125 mg Delayed-Release Tablets for ...

    Benzinga

  5. Stocks To Watch For January 2, 2013

    Benzinga

  6. Weekly CFO Sells Highlight: FII, SLXP, CCK, VCI, WDC, STMP

    GuruFocus

  7. Salix Pharmaceuticals, Ltd. (SLXP) President & CEO ...

    GuruFocus

  8. Benzinga's Top Initiations

    Benzinga

  9. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With ...

    Benzinga

  10. Salix Pharmaceuticals Ltd. Reports Operating Results (10-Q)

    GuruFocus

  11. Weekly Guru Bargains Highlights: HMSY, FB, TSU, SLXP, ANR

    GuruFocus

  12. IBD 50: Cubist Pharma Earnings Beat Expectations

    Investors Business Daily

  13. Salix trounces Q2 estimates

    Investors Business Daily

  14. Salix Pharmaceuticals Ltd. Reports Operating Results (10-Q)

    GuruFocus

  15. Salix Pharmaceuticals Beats, Announces Licensing Deal

    Investors Business Daily

  16. Stocks Turn Mixed; Dillard's Breaks Out

    Investors Business Daily

  17. Futures Mixed On Jobs Data; Elizabeth Arden Spikes

    Investors Business Daily

  18. Stocks Extend Gains; Priceline.com Slides After Hours

    Investors Business Daily

  19. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With ...

    Benzinga

  20. Apple, Other Leaders Shaping Bases In Wild Market

    Investors Business Daily

  21. Health Care Sector Wrap

    FOXBusiness

  22. Stocks Dip In Lower Volume; Cirrus Logic Soars After Hours

    Investors Business Daily

  23. Stocks Down In Lower Volume; Salix Pharma Hammered

    Investors Business Daily

  24. Chicago Bridge & Iron Company N.V, Mercadolibre Among ...

    FOXBusiness

  25. Salix, Progenics Stocks Fall On Drug Approval Delay

    Investors Business Daily

  26. Chicago Bridge & Iron Company N.V, Salix Pharmaceuticals ...

    FOXBusiness

  27. Stock Futures Mixed; Salix, Progenics Tumble

    Investors Business Daily

  28. Benzinga's Top Pre-Market Losers

    Benzinga

  29. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga

  30. Put Spread Purchased in Salix Pharmaceuticals Ahead of ...

    Benzinga

  31. Can Jazz Pharmaceuticals Lift The Ethical Drug Group?

    Investors Business Daily

  32. Biotechs With Upcoming PDUFA Dates

    Benzinga

  33. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga

  34. Salix Pharmaceuticals Ltd. (SLXP) President & CEO ...

    GuruFocus

  35. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga

  36. Medical Stocks Forming Bases Amid Market Sell-Off

    Investors Business Daily

  37. UPDATE: Goldman Sachs Raises Salix Pharmaceuticals' PT

    Benzinga

  38. Salix Pharma

    Investors Business Daily

  39. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    Investors Business Daily

  40. Drugmaker Salix's Q1 Earnings Expected To Soar 68%

    Investors Business Daily

  41. Spain, China Woes Spark Selling; Alcoa Beats Views

    at IBD

  42. Stocks Sharply Lower In Late Afternoon; Apple Dips

    at IBD

  43. Indexes' Losses Pick Up in Afternoon; Apple Off Highs

    at IBD

  44. Stocks Fall Broadly At Midday, But Apple Keeps Rising

    at IBD

  45. Stocks Dip To Quiet Losses; Dell, Cree, Best Buy Gain

    at IBD

  46. Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C ...

    GuruFocus

  47. Salix Pharmaceuticals Ltd. Reports Operating Results (10-K)

    at GuruFocus

  48. UPDATE: Jefferies Raises Price Target on Salix ...

    at Benzinga

  49. UPDATE: Auriga Upgrades Salix Pharmaceuticals to Buy

    at Benzinga

  50. Financial Breakfast: Morning News Summary for February ...

    at Benzinga

  51. Salix Pharmaceuticals

    at IBD

  52. Jazz Rouses Q4 Profit, Sales

    at IBD

  53. Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C ...

    at GuruFocus

  54. Bank of America Sees Buying Opportunity on Salix's Weakness

    at Benzinga

  55. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With ...

    at Benzinga

  56. Top 5 Small-Cap Drug Firms Include Questcor, Cubist

    at IBD

  57. Piper Jaffray Reinforces Bullish Thesis for Salix ...

    at Benzinga

  58. Top 5 Small-Cap Stocks: Salix Pharma, Select Comfort

    at IBD

  59. Salix Pharmaceuticals Ltd. (SLXP) EVP Finance/CFO Adam C ...

    at GuruFocus

  60. Salix, Valeant Display Possible Entry Points

    at IBD

  61. ETF Showdown: Fun With Pharma

    at Benzinga

  62. Goldman Sachs Raises PT on Salix Pharmaceuticals to $46

    at Benzinga

  63. Top 4 Stocks In The Drugs-Generic Industry With The ...

    at Benzinga

  64. Salix Pharmaceuticals (SLXP) Gains 7.3% on Positive ...

    At Market Intelligence Center

  65. Stocks Bounce Back In Big Volume

    at IBD

  66. Progenics Pharma Up 30% on Positive Phase 3 Results

    at Benzinga

  67. Bank of America Raises PO on Salix Pharmaceuticals to $55

    at Benzinga

  68. Jefferies Raises PT on Salix Pharmaceuticals to $50

    at Benzinga

  69. Morning Market Movers

    at Benzinga

  70. Where To Invest: Medical Stocks Defy Market Slump

    at IBD

  71. Salix Submits New NDA, Investors Hope for New Stock ...

    at Benzinga

  72. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With ...

    at Benzinga

  73. Orphan Drug Key Mover For Salix Pharmaceuticals

    at IBD
Marketplace
Trading Center